ArticleAmerican health & drug benefits2017
Impact of Nonadherence to Inhaled Corticosteroid/LABA Therapy on COPD Exacerbation Rates and Healthcare Costs in a Commercially Insured US Population.
Jill R Davis et al.PubMed ↗Full text ↗
No numbers read from the abstract.
24 papers cite it
this paperpooled itcites it